Analyzing outcomes of neoadjuvant and adjuvant treatment for borderline-resectable pancreatic adenocarcinoma in the perioperative period at an academic institution.
Ann Pancreat Cancer
; 32020 Mar.
Article
in En
| MEDLINE
| ID: mdl-32313882
Full text:
1
Database:
MEDLINE
Type of study:
Observational_studies
/
Risk_factors_studies
Language:
En
Journal:
Ann Pancreat Cancer
Year:
2020
Type:
Article
Affiliation country:
United States